Literature DB >> 18046414

mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.

John T Cunningham1, Joseph T Rodgers, Daniel H Arlow, Francisca Vazquez, Vamsi K Mootha, Pere Puigserver.   

Abstract

Transcriptional complexes that contain peroxisome-proliferator-activated receptor coactivator (PGC)-1alpha control mitochondrial oxidative function to maintain energy homeostasis in response to nutrient and hormonal signals. An important component in the energy and nutrient pathways is mammalian target of rapamycin (mTOR), a kinase that regulates cell growth, size and survival. However, it is unknown whether and how mTOR controls mitochondrial oxidative activities. Here we show that mTOR is necessary for the maintenance of mitochondrial oxidative function. In skeletal muscle tissues and cells, the mTOR inhibitor rapamycin decreased the gene expression of the mitochondrial transcriptional regulators PGC-1alpha, oestrogen-related receptor alpha and nuclear respiratory factors, resulting in a decrease in mitochondrial gene expression and oxygen consumption. Using computational genomics, we identified the transcription factor yin-yang 1 (YY1) as a common target of mTOR and PGC-1alpha. Knockdown of YY1 caused a significant decrease in mitochondrial gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, mTOR and raptor interacted with YY1, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1alpha. We have therefore identified a mechanism by which a nutrient sensor (mTOR) balances energy metabolism by means of the transcriptional control of mitochondrial oxidative function. These results have important implications for our understanding of how these pathways might be altered in metabolic diseases and cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046414     DOI: 10.1038/nature06322

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  620 in total

1.  Alpha-lipoic acid supplementation reduces mTORC1 signaling in skeletal muscle from high fat fed, obese Zucker rats.

Authors:  Zhuyun Li; Cory M Dungan; Bradley Carrier; Todd C Rideout; David L Williamson
Journal:  Lipids       Date:  2014-11-01       Impact factor: 1.880

2.  Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function.

Authors:  Klaas Romanino; Laetitia Mazelin; Verena Albert; Agnès Conjard-Duplany; Shuo Lin; C Florian Bentzinger; Christoph Handschin; Pere Puigserver; Francesco Zorzato; Laurent Schaeffer; Yann-Gaël Gangloff; Markus A Rüegg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  The TOR pathway modulates the structure of cell walls in Arabidopsis.

Authors:  Ruth-Maria Leiber; Florian John; Yves Verhertbruggen; Anouck Diet; J Paul Knox; Christoph Ringli
Journal:  Plant Cell       Date:  2010-06-08       Impact factor: 11.277

Review 4.  Feedback on fat: p62-mTORC1-autophagy connections.

Authors:  Jorge Moscat; Maria T Diaz-Meco
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 5.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

6.  Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.

Authors:  Laura Maria Pradella; Martin Lang; Ivana Kurelac; Elisa Mariani; Flora Guerra; Roberta Zuntini; Giovanni Tallini; Alan MacKay; Jorge S Reis-Filho; Marco Seri; Daniela Turchetti; Giuseppe Gasparre
Journal:  Eur J Hum Genet       Date:  2013-02-06       Impact factor: 4.246

Review 7.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  A Genome-wide CRISPR Death Screen Identifies Genes Essential for Oxidative Phosphorylation.

Authors:  Jason D Arroyo; Alexis A Jourdain; Sarah E Calvo; Carmine A Ballarano; John G Doench; David E Root; Vamsi K Mootha
Journal:  Cell Metab       Date:  2016-09-22       Impact factor: 27.287

9.  Why is an energy metabolic defect the common outcome in BMFS?

Authors:  Paolo Degan; Silvia Ravera; Enrico Cappelli
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

Review 10.  mTOR is a key modulator of ageing and age-related disease.

Authors:  Simon C Johnson; Peter S Rabinovitch; Matt Kaeberlein
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.